Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|July 1, 1989
Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease associationJ M Ahearn, J J Calomiris, F M Wigley, et al.
The Journal of Experimental Medicine|April 1, 1996
Antibody response to a T-dependent antigen requires B cell expression of complement receptorsD A Croix, J M Ahearn, A M Rosengard, et al.
The Journal of Experimental Medicine|December 1, 1989
Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2C A Lowell, L B Klickstein, R H Carter, et al.
The Journal of Experimental Medicine|October 1, 1993
Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytesA K Matsumoto, D R Martin, R H Carter, et al.
Molecular Immunology|October 6, 1999
Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP)A M Rosengard, L C Alonso, L C Korb, et al.
The Journal of Experimental Medicine|December 1, 1991
Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitorK R Kalli, P H Hsu, T J Bartow, et al.
Medicine|September 1, 1985
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsetsM C Hochberg, R E Boyd, J M Ahearn, et al.
Lupus|August 2, 2012
Complement fragment C3d is colocalized within the lipid rafts of T cells and promotes cytokine productionO Borschukova, Z Paz, I C Ghiran, et al.
Physiological Measurement|August 1, 2007
Experimental system for ex vivo measurement of murine aortic stiffnessL C Santelices, S J Calano, J C Erhart, et al.
Science (New York, N.Y.)|July 12, 1996
Mechanism of suppression of cell-mediated immunity by measles virusC L Karp, M Wysocka, L M Wahl, et al.
Pageof 4